These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19731022)

  • 41. A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients.
    Sato S; Miyake T; Tobita H; Oshima N; Ishine J; Hanaoka T; Amano Y; Kinoshita Y
    World J Gastroenterol; 2009 Jun; 15(22):2782-6. PubMed ID: 19522030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
    Casado JL; Mena A; Bañón S; Castro A; Quereda C; Moreno A; Pedreira J; Moreno S
    HIV Med; 2016 Jan; 17(1):62-7. PubMed ID: 26122981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exacerbations of oral lichen planus and elevated levels of aminotransferases.
    Bombeccari GP; Tettamanti M; Pallotti F; Spadari F; Giannì AB
    Int J Dermatol; 2017 Aug; 56(8):842-849. PubMed ID: 28474370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment.
    Chojnacki C; Błońska A; Chojnacki J
    Biomed Res Int; 2017; 2017():3204504. PubMed ID: 28630863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients.
    Fabrizi F; Lunghi G; Andrulli S; Pagliari B; Mangano S; Faranna P; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1997 Jul; 12(7):1394-8. PubMed ID: 9249775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statins and elevated liver tests: what's the fuss?
    Onusko E
    J Fam Pract; 2008 Jul; 57(7):449-52. PubMed ID: 18625167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial.
    Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Hecht J; Tio F; Cusi K
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2950-2961. PubMed ID: 28575232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spectrum of liver damage and correlation with clinical and laboratory parameters in HCV infected hemodialysis patients.
    Sezer S; Ozdemir BH; Arat Z; Turan M; Ozdemir NF; Haberal M
    Ren Fail; 2001 Nov; 23(6):807-18. PubMed ID: 11777320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.
    Williams AL; Hoofnagle JH
    Gastroenterology; 1988 Sep; 95(3):734-9. PubMed ID: 3135226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis.
    Masson W; Lobo M; Masson G; Molinero G; Casciato P
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1357-1364. PubMed ID: 33715945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated alanine aminotransferase (ALT) in blood donors: an assessment of the main associated conditions and its relationship to the development of hepatitis C.
    Gonçales Júnior FL; Stucchi RS; Papaiordanou PM; Pavan MH; Gonçales NS; Pinho JR
    Rev Inst Med Trop Sao Paulo; 1998; 40(4):219-24. PubMed ID: 9876434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
    Sheth SG; Flamm SL; Gordon FD; Chopra S
    Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The liver profile in patients with hepatitis C virus and/or fascioliasis.
    Wahib AA; el-Nasr MS; Mangoud AM; el-Shazly AM; Morsy AT
    J Egypt Soc Parasitol; 2006 Aug; 36(2):405-40. PubMed ID: 16927859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease].
    Abel T; Fehér J; Dinya E; Gamal Eldin M; Kovács A
    Orv Hetil; 2009 May; 150(21):989-93. PubMed ID: 19443308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver Biochemistries in Hospitalized Patients With COVID-19.
    Bloom PP; Meyerowitz EA; Reinus Z; Daidone M; Gustafson J; Kim AY; Schaefer E; Chung RT
    Hepatology; 2021 Mar; 73(3):890-900. PubMed ID: 32415860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.
    Tetrault JM; Tate JP; Edelman EJ; Gordon AJ; Lo Re V; Lim JK; Rimland D; Goulet J; Crystal S; Gaither JR; Gibert CL; Rodriguez-Barradas MC; Fiellin LE; Bryant K; Justice AC; Fiellin DA
    J Subst Abuse Treat; 2016 Sep; 68():62-7. PubMed ID: 27431048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.
    Tetrault JM; Tate JP; McGinnis KA; Goulet JL; Sullivan LE; Bryant K; Justice AC; Fiellin DA;
    Alcohol Clin Exp Res; 2012 Feb; 36(2):318-24. PubMed ID: 21797892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
    Vermehren J; Vermehren A; Mueller A; Carlebach A; Lutz T; Gute P; Knecht G; Sarrazin C; Friedrich-Rust M; Forestier N; Poynard T; Zeuzem S; Herrmann E; Hofmann WP
    BMC Gastroenterol; 2012 Mar; 12():27. PubMed ID: 22453133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C.
    Tsui JI; Cheng DM; Libman H; Bridden C; Saitz R; Samet JH
    J Stud Alcohol Drugs; 2013 Mar; 74(2):266-70. PubMed ID: 23384374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.